Skip to main content
OpenTrials
Completed

NCT Number: NCT03246516

Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oesophageal Carcinoma Digestive System Diseases Digestive System Neoplasms Esophageal Diseases Esophageal Neoplasms Gastric Adenocarcinoma Gastrointestinal Diseases Gastrointestinal Neoplasms Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier de Boulogne sur mer, Boulogne-sur-Mer, France

Loading trial locations.

About this study

Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors.

We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age ≥ 18 years
  • oesophageal, oeso-gastric junction or gastric cancer non treated cancer
  • patient informed of his diagnosis
  • speak fluent french

Exclusion criteria

  • history of cancer
  • psychological history
  • patient under guardianship-
  • fortuitous diagnosis of cancer

Treatment and study plan

Questionnaire

Other

Auto and hetero questionnaires:

  • STAI Y B, State-Trait Anxiety Inventoriage
  • Brief COPE
  • RHHI-24, Revised Health Hardiness Inventory
  • IPQ-R, Illness Perception Questionnaire

Primary outcomes

  1. Time limit of first doctor consultation

    Time frame: baseline

    Median time between date of symptoms appearance and date of first consultation

Secondary outcomes

  1. Time limit of system of care

    Time frame: baseline

    Median time between date of he beginning of clinical investigations and the beginning of treatment

  2. cTNM Stage

    Time frame: baseline

    Stage TNM by distinguishing the early stages (I, II) vs. (III, IV)

  3. clinical variables (i.e medical history, symptoms, entry into care pathway)

    Time frame: baseline

    clinical variables associated with time of first doctor consultation

  4. Socio-cognitive variables

    Time frame: baseline

    Socio-cognitive variables associated with time of first doctor consultation

  5. Emotional variables

    Time frame: baseline

    Emotional variables associated with time of first doctor consultation

  6. Survival

    Time frame: At 3 years

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Collaborators

  • University of Lille Nord de France

Registry information

Official study title

Individual and Socio-economic Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

Acronym: DELOGAST

Important dates

Study start
2017
Primary completion
2025
Study completion
2025
First posted
Aug 11, 2017
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.